Also trades as: YPSN.SW (SIX) · $vol 6M · 0QLQ.L (LSE) · $vol 1M

$436.55

+0.00 (+0.00%)

OTC · Healthcare · Medical - Specialties · Tech Score Sell · Power 42 · $5.7B mcap · 4M float · 0.0000% daily turnover · Short 100% of daily vol

Revenue

$731M -2.4% ▼

5Y CAGR: +12.6%

Gross Profit

$315M +7.7% ▲

5Y CAGR: +27.1%

Operating Income

$246M +118.1% ▲

5Y CAGR: +217.0%

Net Income

$222M +153.6% ▲

5Y CAGR: +107.2%

EPS (Diluted)

$16.30 +154.3% ▲

5Y CAGR: +104.1%

EBITDA

$326M +71.0% ▲

5Y CAGR: +38.6%

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$465M	$497M	$548M	$749M	$731M
YoY Growth	+15.2%	+7.0%	+10.3%	+36.5%	-2.4%
Cost of Revenue	$351M	$357M	$359M	$457M	$416M
Gross Profit	$114M	$141M	$189M	$292M	$315M
Gross Margin	24.5%	28.3%	34.5%	39.0%	43.0%
R&D Expenses	$22M	$29M	$0	$34M	$40M
SG&A Expenses	$89M	$103M	$108M	$126M	$90M
Operating Expenses	$89M	$103M	$103M	$179M	$69M
Operating Income	$24M	$37M	$86M	$113M	$246M
Operating Margin	5.2%	7.5%	15.7%	15.1%	33.7%
Interest Expense	$2M	$2M	$5M	$7M	$3M
Income Before Tax	$26M	$57M	$82M	$104M	$241M
Tax Expense	$2M	$5M	$4M	$17M	$19M
Net Income	$23M	$51M	$78M	$88M	$222M
Net Margin	5.0%	10.3%	14.3%	11.7%	30.4%
EPS (Diluted)	$1.82	$3.82	$5.74	$6.41	$16.30
EBITDA	$92M	$138M	$162M	$191M	$326M
Shares Outstanding	13M	13M	14M	14M	14M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q2	FY2026 Q4
Revenue	$147M	$293M	$162M	$162M	$212M	$212M	$362M	$369M
Cost of Revenue	$81M	$192M	$103M	$103M	$125M	$125M	$212M	$204M
Gross Profit	$66M	$101M	$59M	$59M	$87M	$87M	$150M	$165M
Gross Margin	44.9%	34.5%	36.2%	36.2%	41.1%	41.1%	41.4%	44.6%
R&D Expenses	$27M	$23M	$0	$0	$28M	$28M	$19M	$21M
SG&A Expenses	$28M	$57M	$30M	$30M	$33M	$33M	$56M	$34M
Operating Expenses	$43M	$55M	$38M	$38M	$51M	$51M	$75M	$55M
Operating Income	$23M	$46M	$20M	$20M	$36M	$36M	$75M	$110M
Operating Margin	15.8%	15.8%	12.5%	12.5%	17.0%	17.0%	20.7%	29.8%
Interest Expense	$1M	$3M	$2M	$2M	$2M	$2M	$2M	$1M
Income Before Tax	$22M	$44M	$18M	$18M	$34M	$34M	$147M	$94M
Tax Expense	$911K	$2M	$2M	$2M	$7M	$7M	$8M	$11M
Net Income	$21M	$42M	$16M	$16M	$27M	$27M	$139M	$83M
Net Margin	14.3%	14.3%	10.1%	10.1%	12.9%	12.9%	38.4%	22.5%
EPS (Diluted)	$1.53	$3.06	$1.19	$1.19	$2.01	$2.01	$10.17	$6.13
EBITDA	$28M	$57M	$44M	$44M	$44M	$44M	$187M	$155M
Shares Outstanding	14M	14M	14M	14M	14M	14M	14M	14M

YPHDF OTC